Cargando…

Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings

More than 300 million people worldwide are diagnosed with a chronic hepatitis B virus (HBV) infection. Nucleos(t)ide viral polymerase inhibitors are available on the market and can efficiently treat patients with chronic HBV. However, life-long treatment is needed as covalently closed circular DNA (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tricot, Tine, Thibaut, Hendrik Jan, Abbasi, Kayvan, Boon, Ruben, Helsen, Nicky, Kumar, Manoj, Neyts, Johan, Verfaillie, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869365/ https://www.ncbi.nlm.nih.gov/pubmed/35203482 http://dx.doi.org/10.3390/biomedicines10020268

Ejemplares similares

Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals
por: Tricot, Tine, et al.
Publicado: (2018)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†)
por: De Clercq, Erik, et al.
Publicado: (2010)

Dynamic regulation of EZH2 from HPSc to hepatocyte-like cell fate
por: Pistoni, Mariaelena, et al.
Publicado: (2017)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
por: Lucifora, Julie, et al.
Publicado: (2018)

The Interactions Between HBV and the Innate Immunity of Hepatocytes
por: Megahed, Fayed Attia Koutb, et al.
Publicado: (2020)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes
por: Yan, Ran, et al.
Publicado: (2015)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

Antiviral therapy of chronic HBV infection in pregnancy
por: Nikolajuk-Stasiuk, Julita, et al.
Publicado: (2016)

A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice
por: Boudewijns, Robbert, et al.
Publicado: (2021)

Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery
por: Tricot, Tine, et al.
Publicado: (2022)

Identification of Therapeutic Targets for the Selective Killing of HBV-Positive Hepatocytes
por: Huang, Chien-Jung, et al.
Publicado: (2021)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Ye, Lei, et al.
Publicado: (2017)

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
por: Hu, Zili, et al.
Publicado: (2022)

1248. Relationship Between ALT and New HBV Biomarkers in HBV/HIV Coinfected Persons Started on Antiviral Therapy
por: Rouster, Susan D, et al.
Publicado: (2022)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
por: Gailhouste, Luc, et al.
Publicado: (2021)

Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma
por: de Beijer, Monique T.A., et al.
Publicado: (2022)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication
por: Barral, Karine, et al.
Publicado: (2011)

Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
por: Li, Ping, et al.
Publicado: (2021)

Editorial: Interferon and its antiviral effect in response to HBV infection
por: Song, Hongxiao, et al.
Publicado: (2023)

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2022)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

Author Correction: Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Ye, Lei, et al.
Publicado: (2018)

Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV Infection
por: Zhang, Hong, et al.
Publicado: (2020)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model
por: Sang, Xiuxiu, et al.
Publicado: (2017)

Establishment of stable cell lines in which the HBV genome replicates episomally for evaluation of antivirals
por: Sun, Suofeng, et al.
Publicado: (2018)

Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes
por: Ancey, Pierre-Benoit, et al.
Publicado: (2015)

ACE2 and TMPRSS2 Expression in Hepatocytes of Chronic HBV Infection Patients
por: Hu, Xiao-Xiao, et al.
Publicado: (2021)

ATOH8 promotes HBV immune tolerance by inhibiting the pyroptotic pathway in hepatocytes
por: Liu, Xiaofei, et al.
Publicado: (2023)

HBV Life Cycle: Entry and Morphogenesis
por: Schädler, Stephanie, et al.
Publicado: (2009)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Tyrosine 146 of the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_29ond4m4ra6dgk0epcaeoeondc